Perioperative pain
Conditions
Interventions
Group A:Hydromorphone PCIA
Group B:0.9% Normal Saline
Sponsors
Chengdu Qingbaijiang District People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Volunteer to participate and sign the informed consent in writing; (2) Patients with advanced malignant tumors undergoing selective tumor embolization; (3) The activity status score established by the Eastern Cooperative Oncology Group (ECOG) <= 2 points; (4) The expected survival period is greater than 3 months.
Exclusion criteria
Exclusion criteria: (1) Severe coagulation disorder that cannot be corrected; (2) History of serious cardiovascular and respiratory diseases; (3) Patients who are allergic to test drugs or contrast agents; (4) Patients with opioid addiction; (5) Patients with cognitive dysfunction; (6) Those who have participated in other clinical research in the past 30 days. (7) The sponsor or investigator directly involved in the trial or their family members; (8) Those who are judged by the investigator to be unsuitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction evaluation;Number of breakthrough pain per day;Postoperative hospital stay;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactCao lei
Chengdu Qingbaijiang District People's Hospital
Outcome results
None listed